NeoGenomics shares are trading lower after Natera won a preliminary injuction in a patent infringement lawsuit against NeoGenomics' RaDar test.
Portfolio Pulse from Benzinga Newsdesk
NeoGenomics shares are trading lower due to a preliminary injunction granted to Natera in a patent infringement lawsuit against NeoGenomics' RaDar test.
December 28, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NeoGenomics faces a negative impact on its stock price following a preliminary injunction in favor of Natera for a patent infringement lawsuit.
The preliminary injunction against NeoGenomics' RaDar test suggests potential legal challenges and disruptions in its operations, which could negatively affect investor sentiment and the company's financial outlook in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100